Search Results for Trans-Pacific Partnership

Showing 1 – 3

Final TPP Agreement Draws Ire from Both Sides over Biologics Exclusivity By Zachary Brennan - Published 05 October 2015

Pharmaceutical industry groups and nonprofits expressed disappointment Monday over a compromise in the Trans-Pacific Partnership (TPP) on biologics data exclusivity.

Categories: News, Asia, Canada, Oceania, US, Biologics and biotechnology, Distribution, Government affairs, Postmarket surveillance, Regulatory intelligence, Regulatory strategy

Tags: TPP, Trans-Pacific Partnership, biologics exclusivity, BIO, PhRMA, MSF

Biologics Exclusivity Still Central in Trade Talk Debate By Michael Mezher - Published 05 June 2015

The length of data exclusivity for biologics remains one of the most controversial aspects of the Trans-Pacific Partnership (TPP), which is poised to be the largest free-trade deal in history.

Categories: News, Asia, Canada, Latin America and Caribbean, Oceania, US, Biologics and biotechnology, Government affairs, Regulatory strategy

Tags: Trans-Pacific Partnership, TPP, biologics exclusivity, regulatory data protection, PhRMA, intellectual property, IP, patents

Trade Talks Stumble Over Biologics Data Exclusivity By Michael Mezher - Published 11 February 2015

Trade officials from around the world are potentially just months away from completing what would be the largest free-trade deal in history, but the completion of that deal is reportedly struggling to get past an issue related to the regulation of biologics.

Categories: Japan, Canada, Latin America and Caribbean, Oceania, US, Biologics and biotechnology, Government affairs, Regulatory strategy

Tags: Trans-Pacific Partnership, TPP, intellectual property, patents, regulatory data protection, data exclusivity, USTR, Michael Froman